Literature DB >> 11008077

Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients.

J Carlsen1, J C Toft, S A Mortensen, H Arendrup, J Aldershvile, B Hesse.   

Abstract

BACKGROUND: Several studies have explored the feasibility of using myocardial perfusion imaging to detect allograft vasculopathy after heart transplantation. We undertook the present prospective consecutive study to comparatively evaluate the role of serial myocardial perfusion single-photon emission computed tomography (SPECT) scanning and coronary arteriography (CAG) in detecting coronary artery stenosis suitable for coronary angioplasty in heart transplant recipients.
METHODS: Within a 2-week interval during a follow-up period of 5.6 (95% confidence limits 2.1 to 12) years, 255 serial CAGs and myocardial perfusion scintigraphies were performed in 67 patients. Arteriography and scintigraphy were performed once yearly after heart transplantation. We retrospectively analyzed the data.
RESULTS: Myocardial scintigraphy showed pathologic reversible defects in 9 out of 67 patients. Four of these patients had significant (>50% and also >70%) focal segmental stenosis in the middle and proximal parts of the coronary arteries (Type A lesions), 1 had diffuse and circumferential narrowing in the distal parts (Type B lesions), whereas CAG showed no lesions in the remaining 4 patients. The patients with significant Type A lesions were revascularized with percutaneous coronary angioplasty. Coronary arteriography showed that 1 patient had extensive Type A and Type B lesions, whereas myocardial perfusion scans detected no. The predictive value of a negative (normal) SPECT was 98% (95% confidence limits 94% to 100%) for the detection of lesions suited for revascularization.
CONCLUSIONS: Annual myocardial SPECT seems well suited to screen for significant coronary artery stenosis. A SPECT study without reversible defects virtually excludes lesions suitable for coronary artery revascularization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008077     DOI: 10.1016/s1053-2498(00)00167-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  8 in total

Review 1.  Imaging in patients after cardiac transplantation and in patients with ventricular assist devices.

Authors:  Bhanu Gupta; Dany Jacob; Randall Thompson
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

2.  Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients.

Authors:  Alain Manrique; Mathieu Bernard; Anne Hitzel; Michael Bubenheim; Christophe Tron; Denis Agostini; Alain Cribier; Pierre Véra; Jean Paul Bessou; Michel Redonnet
Journal:  J Nucl Cardiol       Date:  2010-02-12       Impact factor: 5.952

3.  New developments for the detection and treatment of cardiac vasculopathy.

Authors:  Kevin J Clerkin; Ziad A Ali; Donna M Mancini
Journal:  Curr Opin Cardiol       Date:  2017-02-15       Impact factor: 2.161

4.  Myocardial perfusion imaging for cardiac allograft vasculopathy assessment: Evidence grows, but questions remain.

Authors:  Deepak Acharya; Indranee Rajapreyar
Journal:  J Nucl Cardiol       Date:  2017-11-07       Impact factor: 5.952

Review 5.  Diagnosis and management of coronary allograft vasculopathy in children and adolescents.

Authors:  Nathalie Dedieu; Gerald Greil; James Wong; Matthew Fenton; Michael Burch; Tarique Hussain
Journal:  World J Transplant       Date:  2014-12-24

6.  Identification of coronary artery disease in the pediatric cardiac transplant patient.

Authors:  Jacqueline Maiers; Roger Hurwitz
Journal:  Pediatr Cardiol       Date:  2007-09-21       Impact factor: 1.655

7.  Evolving concepts and treatment strategies for cardiac allograft vasculopathy.

Authors:  Rodolfo Denadai Benatti; David O Taylor
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

8.  Clinical Utility of SPECT in the Heart Transplant Population: Analysis From a Single Large-volume Center.

Authors:  Jack Aguilar; Robert J H Miller; Yuka Otaki; Balaji Tamarappoo; Sean Hayes; John Friedman; Piotr J Slomka; Louise E J Thomson; Michelle Kittleson; Jignesh K Patel; Jon A Kobashigawa; Daniel S Berman
Journal:  Transplantation       Date:  2022-03-01       Impact factor: 5.385

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.